International Pr Comms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from International Pr Comms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In International Pr Comms Today - Breaking & Trending Today

MEDSIR & Debiopharm Initiate Clinical Collaboration to Explore Potential Synergy of Debio 0123 & Sacituzumab Govitecan in Advanced Breast Cancer

Published: May 28, 2024

The WIN-B is a Phase Ib/II investigator-sponsored trial (IST) that will evaluate the safety and preliminary efficacy of the Debiopharm's potent Wee-1 inhibitor Debio 0123 in combination with Gilead's

Source: finanznachrichten.de

Related Topics:

City OfUnited KingdomUnited StatesJavier CortDebiopharm DebioTim RobinsonSacituzumab Govitecan TrodelvySelva RajanEsteban Rodrigo ImedioCarles BerlosoAmerican Association For Cancer ResearchUniversity Of BristolAmerican Cancer SocietyHead Of CommunicationsGilead Sciences IncInternational Pr CommsSacituzumab GovitecanGilead SciencesExecutive Medical DirectorPrincipal InvestigatorInvestigator Sponsor TrialAmerican AssociationCancer ResearchMohd AdzmiIwan Abdul Rahman